Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study (Unknown)
Free access
- New search for: Yu, Tiantian
- New search for: Cai, Qing-Qing
- New search for: Zhai, Qiong-Li
- New search for: Li, Ling
- New search for: Fang, Xiaosheng
- New search for: Li, Jianyong
- New search for: Sun, Ruifang
- New search for: Yang, Hanjin
- New search for: Wang, Zhaoming
- New search for: Qian, Wenbian
- New search for: Xu-Monette, Zijun Y.
- New search for: Young, Ken H.
- New search for: Yu, Li
- New search for: Yu, Tiantian
- New search for: Cai, Qing-Qing
- New search for: Zhai, Qiong-Li
- New search for: Li, Ling
- New search for: Fang, Xiaosheng
- New search for: Li, Jianyong
- New search for: Sun, Ruifang
- New search for: Yang, Hanjin
- New search for: Wang, Zhaoming
- New search for: Qian, Wenbian
- New search for: Xu-Monette, Zijun Y.
- New search for: Young, Ken H.
- New search for: Yu, Li
In:
Leukemia & Lymphoma
;
63
, 13
;
3082-3091
;
2022
- Article (Journal) / Electronic Resource
-
Title:Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study
-
Contributors:Yu, Tiantian ( author ) / Cai, Qing-Qing ( author ) / Zhai, Qiong-Li ( author ) / Li, Ling ( author ) / Fang, Xiaosheng ( author ) / Li, Jianyong ( author ) / Sun, Ruifang ( author ) / Yang, Hanjin ( author ) / Wang, Zhaoming ( author ) / Qian, Wenbian ( author )
-
Published in:Leukemia & Lymphoma ; 63, 13 ; 3082-3091
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2022-11-10
-
Size:10 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 63, Issue 13
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3019
-
The enigma of LAG3 receptor in hematological malignanciesKreiniz, Natalia / Polliack, Aaron / Tadmor, Tamar et al. | 2022
- 3021
-
Development of a distributed international patient data registry for hairy cell leukemiaAndritsos, Leslie A. / Anghelina, Mirela / Neal, Jasmine / Blachly, James S. / Mathur, Puneet / Lele, Omkar / Dearden, Claire / Iyengar, Sunil / Cross, Matthew / Zent, Clive S. et al. | 2022
- 3032
-
T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscapeKazandjian, Dickran / Kowalski, Andrew / Landgren, Ola et al. | 2022
- 3044
-
Brain-derived neurotrophic factor: focus on the pathogenesis of multiple myeloma and the development of treatment-induced peripheral neuropathyŁuczkowska, Karolina / Kulig, Piotr / Baumert, Bartłomiej / Machaliński, Bogusław et al. | 2022
- 3052
-
Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphomaOluwole, Olalekan O. / Chen, Jenny M.H / Chan, Keith / Patel, Anik R. / Jansen, Jeroen P. / Keeping, Sam / Zheng, Yan / Snider, Julia T. / Locke, Frederick L. et al. | 2022
- 3063
-
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II studyStamatoullas, Aspasia / Ghesquières, Hervé / Feugier, Pierre / André, Marc / Le Bras, Fabien / Gac, Anne-Claire / Borel, Cécile / Gastinne, Thomas / Quittet, Philippe / Morschhauser, Franck et al. | 2022
- 3072
-
Extra copy number of BCL2 is correlated with increased BCL-2 protein expression and poor survival in diffuse large B-cell lymphoma treated with chemoimmunotherapyHwang, Hee Sang / Sung, Hyun-Jung / Kim, Mee-Jeong / Yoon, Dok Hyun / Park, Chan-Sik / Huh, Jooryung / Go, Heounjeong et al. | 2022
- 3082
-
Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter studyYu, Tiantian / Cai, Qing-Qing / Zhai, Qiong-Li / Li, Ling / Fang, Xiaosheng / Li, Jianyong / Sun, Ruifang / Yang, Hanjin / Wang, Zhaoming / Qian, Wenbian et al. | 2022
- 3092
-
Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimen for blastic plasmacytoid dendritic cell neoplasm patients in complete remission: a single center studyLu, Yue / Sun, Rui-Juan / Zhang, Jian-Ping / Xu, Fang / Du, Zhi-Cong / Tong, Ge-Le / Wang, Yun / Lu, Dao-Pei et al. | 2022
- 3100
-
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to considerButelet, Alexandre / Poulain, Stéphanie / Jeanpierre, Emmanuelle / Srour, Micha / Nudel, Morgane / Chauvet, Paul / Bauters, Anne / Susen, Sophie / Dupont, Annabelle / de Charette, Marie et al. | 2022
- 3105
-
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatmentAbbas, Hussein A. / Ayoub, Edward / Sun, Hanxiao / Kanagal-Shamanna, Rashmi / Short, Nicholas J. / Issa, Ghayas / Yilmaz, Musa / Pierce, Sherry / Rivera, Daniel / Cham, Brent et al. | 2022
- 3117
-
Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remissionNagata, Akihito / Otsuka, Yuki / Konuma, Ryosuke / Adachi, Hiroto / Wada, Atsushi / Kishida, Yuya / Konishi, Tatsuya / Yamada, Yuta / Nagata, Ryohei / Noguchi, Yuma et al. | 2022
- 3128
-
Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomesLalayanni, Chrysavgi / Demosthenous, Christos / Iskas, Michail / Kelaidi, Charikleia / Papathanasiou, Maria / Syrigou, Antonia / Athanasiadou, Anastasia / Papalexandri, Apostolia / Batsis, Ioannis / Vardi, Anna et al. | 2022
- 3138
-
Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST studyRitchie, Ellen / Al-Janadi, Anas / Kessler, Craig / Scherber, Robyn / Kalafut, Tricia / Ren, Haobo / Mesa, Ruben et al. | 2022
- 3154
-
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaWei, Yue / Zheng, Hong / Lockyer, Pamela Pennington / Darbaniyan, Faezeh / Li, Ziyi / Kanagal-Shamanna, Rashmi / Soltysiak, Kelly A. / Yang, Hui / Ganan-Gomez, Irene / Montalban-Bravo, Guillermo et al. | 2022
- 3165
-
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registryBuckstein, Rena / Chodirker, Lisa / Mozessohn, Lee / Yee, Karen W.L / Geddes, Michelle / Zhu, Nancy / Shamy, April / Leitch, Heather A. / Christou, Grace / Banerji, Versha et al. | 2022
- 3175
-
Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor?Canon, Alice / Roy, Lydia / Chevalier, Xavier / Giraudier, Stéphane / Eymard, Florent et al. | 2022
- 3181
-
Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemiaCai, Zihong / Liu, Yiqian / Tang, Bingqing / Wu, Zhengwei / Wang, Zhixiang / Lin, Ren / Xu, Xiuli / Huang, Zicong / Ou, Jiawang / Li, Xiaofang et al. | 2022
- 3191
-
Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysisNamjoshi, Natasha S. / Keegan, Theresa H. M. / Li, Qian C. / Chung, Jong H. / Rosenthal, Jennifer L. / Winestone, Lena E. / Muffly, Lori / Malogolowkin, Marcio H. / Alvarez, Elysia M. et al. | 2022
- 3200
-
Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patientsZak, Taylor / Gao, Juehua / Behdad, Amir / Mehta, Jayesh / Altman, Jessica K. / Ji, Peng / Lu, Xinyan / Sukhanova, Madina et al. | 2022
- 3208
-
Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-CTibout, Pauline / Ledjiar, Omar / Athale, Uma / Rayar, Meera / Kulkarni, Ketan / Truong, Tony / Cellot, Sonia / Bittencourt, Henrique / Pelland-Marcotte, Marie-Claude / Tran, Thai Hoa et al. | 2022
- 3217
-
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphomaWatson, Leisa R. / Lew, Thomas E. / Fox, Lucy C. / Khot, Amit / van der Weyden, Carrie et al. | 2022
- 3222
-
Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10Behdad, Amir / Schipma, Matthew John / Ma, Shuo / Chen, Yi-Hua / Chen, Qing Ching et al. | 2022
- 3227
-
Transcriptional deregulation of LSD1 and LSD2 is associated with cytogenetic risk in chronic lymphocytic leukemiaCosta, Daniel Freitas da / Filiú-Braga, Luma Dayane de Carvalho / Silva-Carvalho, Amandda Évelin / Schiavinato, Josiane Lilian / Vasconcelos, Maria Catarina Cals de / Figueiredo-Pontes, Lorena Lôbo de / Lucena-Araujo, Antonio Roberto / Saldanha-Araujo, Felipe et al. | 2022
- 3232
-
Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)Ball, Brian J. / Arslan, Shukaib / Koller, Paul / Ngo, Dat / Afkhami, Michelle / Salhotra, Amandeep / Al-Malki, Monzr / Aribi, Ahmed / Ali, Haris / Sandhu, Karamjeet et al. | 2022
- 3237
-
Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patientsDurinikova, Anna / Folta, Adam / Pardy, Filip / Svaton, Jan / Drncova, Marie / Weinbergerova, Barbora / Cetkovsky, Petr / Racil, Zdenek / Jindra, Pavel / Szotkowski, Tomas et al. | 2022
- 3241
-
Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin featuresZibara, Victor / Sen, Filiz / Scordo, Michael / Falchi, Lorenzo et al. | 2022
- 3245
-
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agentsZainaldin, Carl / Arora, Sankalp / Bathini, Srilakshmi / Gupta, Udita / Pandya, Vishruti / Bae, Sejong / Worth, Sarah / Bachiashvili, Kimo / Bhatia, Ravi / Godby, Kelly et al. | 2022
- 3249
-
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myelomaLei, Matthew M. / Tavares, Erica / Buzgo, Evan / Lou, Uvette / Raje, Noopur / Yee, Andrew J. et al. | 2022
- 3253
-
Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemiaPatil, Paurnima / Toprak, Umut H. / Seufert, Julian / Braun, Till / Bernhart, Stephan H. / Wiehle, Laura / Müller, Annika / Schlesner, Matthias / Herling, Marco / Lichter, Peter et al. | 2022
- 3257
-
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AMLLontos, Konstantinos / Tsagianni, Anastasia / Agha, Mounzer / Raptis, Anastasios / Hou, Jing-Zhou / Farah, Rafic / Redner, Robert L. / Im, Annie / Dorritie, Kathleen A. / Sehgal, Alison et al. | 2022
- 3261
-
Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemiaMukae, Junichi / Sadato, Daichi / Toya, Takashi / Watanabe, Satoru / Hirama, Chizuko / Konuma, Ryosuke / Shimizu, Hiroaki / Najima, Yuho / Kobayashi, Takeshi / Kato, Motohiro et al. | 2022
- 3265
-
Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathwayCarter-Brzezinski, Luke / Davies, Elizabeth / Norman, Jane / Rubio, Lourdes / Dixon, Christopher / Brett, Sarah / Dunne, Tony / Iqbal, Shahid / Dignan, Fiona L. / Ahmad, Shazaad et al. | 2022
- 3268
-
Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysisAmanam, Idoroenyi / Ngo, Dat / Pullarkat, Vinod / Aldoss, Ibrahim et al. | 2022